(Last Reviewed :  21/05/2009  )

 

 
Latest News

On 12 May 2009, the Australian Government released its innovation policy agenda to 2020.

Powering Ideas: An Innovation Agenda for the 21st Century

The agenda draws on the Pharmaceuticals Industry Strategy Group Final Report and other reports.

Elements of the agenda were included in the 2009-10 Budget announcements.
 

 
Release of Final Report

Senator the Hon Kim Carr issued a media release to announce the release of the Final Report of the Pharmaceuticals Industry Strategy Group (the PISG) on Friday 30 January 2009. Download the Final Report as a PDF (3,697 KB) or an RTF (1.17 MB). The Executive Summary is available as a PDF (912 KB).
 


On 26 May 2008, the Minister for Innovation, Industry, Science and Research, Senator the Hon Kim Carr issued a media release to announce the  terms of reference [PDF 16 KB] for the PISG.

The PISG was tasked with examining the drivers and barriers to attracting new internationally competitive and sustainable manufacturing, R&D and clinical trials investment in the pharmaceuticals sector.

The PISG was co-chaired by Dr Brian McNamee, the Chief Executive Officer and Managing Director of CSL and Mr Craig Pennifold, the Head of the Innovation Division, within the Department of Innovation, Industry, Science and Research.

On 20 October 2008, the Minister issued a media release about the PISG's  Directions Paper [PDF 407 KB]. The PISG then consulted more broadly and refined its proposals to produce a Final Report.

The PISG provided its Final Report to the Minister in December 2008. The Final Report provides an overview of the Australian and global pharmaceuticals industries, a discussion of the barriers and drivers to investment in the Australian industry, and explores a strategic framework to secure a sustainable future that will deliver a net benefit to Australia.

A copy of the Final Report [PDF 3,697 KB] is available here. A copy of the Executive Summary [PDF 912 KB] is available here. The Final Report is also available as an RTF document [1.17 MB].

The PISG was comprised of key industry and union leaders. It met six times: on 7 July, 11 August, 19 September, 24 October, 19 November and 5 December 2008.

Members of the PISG

Name

Position

Organisation

Dr Brian McNamee, AO (Co‑Chair)

Chief Executive Officer and Managing Director

CSL Limited

Mr Craig Pennifold (Co‑Chair)

Head of Innovation Division

Department of Innovation, Industry, Science and Research

Mr Nixon Apple Industry and Economic Adviser Australian Manufacturing Workers Union

Dr Graeme Blackman

Managing Director

Institute of Drug Technology Limited

Mr Dan Brown

Managing Director

Genzyme Australasia Pty Ltd

Mr Ian Chalmers

Chief Executive Officer

Medicines Australia

Dr Greg R Collier

CEO and Managing Director

ChemGenex Pharmaceuticals Limited

Mr Peter Cook

CEO and Managing Director

Biota Holdings Limited

Mr Richard Davies

then Managing Director

Amgen Australia Pty Ltd

Mr Joe de Bruyn

National Secretary and Treasurer

Shop, Distributive and Allied Employees Union

Mr Will Delaat  

Chair

Pharmaceuticals Industry Council

Mr Charlie Donnelly

National Secretary

National Union of Workers

Ms Cait O'Connor

National Policy and Research Officer

Australian Workers' Union

Ms Alison Finger

then Managing Director

Bristol-Myers Squibb Australia Pty Ltd

Ms Di Ford

then Executive Director

Generic Medicines industry Association

Mr Mitch Kirkman

Manager - Process, Training and Quality

Novartis Pharmaceuticals Australia Pty Ltd

Mr John Latham

Regional Director

Pfizer Australia / Pfizer New Zealand

Dr Anna Lavelle

Chief Executive Officer

AusBiotech Ltd

Professor Graham Macdonald

Chair

Pharmaceuticals Education Council

Mr John Montgomery

Chief Executive Officer

Alphapharm

Dr Tim Oldham

President, Asia Pacific

Hospira

Dr Alan Robertson

Chief Executive Officer

Pharmaxis Ltd

Dr Merilyn Sleigh

Chief Executive Officer

InAvanti

Mr Ken Windle

Chairman & CEO

Advent Pharmaceuticals

For more information about the Pharmaceuticals Industry Strategy Group please contact:

The Pharmaceuticals Industry Strategy Group Secretariat
Department of Innovation, Industry, Science and Research
GPO Box 9839
CANBERRA ACT 2601
Australia

Tel: +61 2 6213 6187
Email